Products

Care Portal
Empatica
Clinical Decision Support & Reference
Care Portal is a web-based component of the Empatica Health Monitoring Platform, designed for professionals to manage and monitor participants in various care settings and research studies. It integrates data collected from Empatica’s medical-grade wearables, such as EmbracePlus and EmbraceMini, which continuously measure physiological parameters like heart rate, electrodermal activity, motion, and skin temperature. What […]
Empatica Health Monitoring Platform
Empatica
Clinical Decision Support & Reference
Empatica Health Monitoring Platform offers a full-stack digital health solution with FDA-cleared wearables and AI-powered analytics for continuous physiological monitoring and digital biomarker development in research and clinical care.

See all 2 products →

About Empatica

Empatica is a healthcare AI company that develops medical-grade wearable sensor hardware and a cloud platform for continuous remote physiological monitoring and digital biomarker development. Their FDA-cleared Empatica Health Monitoring Platform provides accurate, continuous health insights for researchers and clinicians, collected in real-world settings. This end-to-end remote monitoring solution is applicable and scalable to numerous therapeutic areas, collecting and monitoring raw data and digital biomarkers across all phases of clinical trials using FDA-clecleared medical technology and a powerful software suite.

Empatica offers multimodal wearables, patient and caregiver mobile applications, raw data access for research, and machine-learning analytics for biosignals. They provide regulated epilepsy and respiratory-infection monitoring solutions with regional medical device certifications and privacy compliance. Their products support clinical trials, research, and everyday care across a range of neurological and health conditions, including epilepsy and Parkinson’s. More than half of the top 20 pharmaceutical companies utilize the Empatica Health Monitoring Platform to track treatment impact and develop novel digital biomarkers for use as digital endpoints.

The company’s technology is designed to collect high-quality physiological data and digital biomarkers, facilitating research and improving patient outcomes. Empatica’s platform uses a combination of biosensors to detect unique components of human physiology, which are then distilled into AI-based algorithms to continuously and remotely monitor autonomic activity, movement, sleep, and cardiac activity. They also offer services such as algorithm integration and endpoint hosting, allowing sponsors to deploy external measures within a single wearable/software ecosystem.

Focus Areas

remote patient monitoring digital biomarkers wearable technology AI in healthcare epilepsy monitoring Parkinson's monitoring sleep tracking stress monitoring clinical trials decentralized clinical trials

Business Intelligence

TechnologyEmpatica Health Monitoring Platform (cloud-based, AI-driven, integrates wearable data, digital biomarkers, Cloud API for EHR/CTMS integration), edge computing on wearables

What Physicians Need to Know

Remote Patient Monitoring
Empatica offers a comprehensive remote patient monitoring platform that utilizes medical-grade wearables (EmbracePlus and EmbraceMini) to continuously collect physiological data in real-world settings. This data is streamed to a dedicated mobile app and then securely stored in the Empatica Cloud, accessible via a Care Portal for healthcare providers. The platform is designed to ease the burden on healthcare workers, enable early intervention, reduce ER visits and hospital readmissions, and improve the quality of care for thousands of patients with chronic conditions. It supports monitoring for various conditions, including surgical, medical, oncology, and hemodialysis patients, as well as the elderly at home. The platform also includes an SDK for integration into existing healthcare provider infrastructures and EHRs.
Digital Biomarkers
Empatica specializes in developing and utilizing FDA-cleared digital biomarkers, offering over 300 digital measures from a single solution. These non-invasive, objective, and continuous measurements of physiological and behavioral parameters are collected via wearable sensors, providing a deeper understanding of disease progression, treatment effectiveness, and patient response in real-world settings. Empatica's platform supports the collection of validated sleep and physiological biomarkers, enabling consistent, high-quality endpoint generation in clinical trials. They are pioneers in digital biomarker development, including the first FDA-cleared digital biomarker in neurology.
Wearable Technology
Empatica's core technology revolves around its medical-grade wearables, EmbracePlus and EmbraceMini. These smartbands are equipped with advanced sensors, including optical pulse sensing, skin conductance, temperature, and movement sensors (accelerometer, gyroscope, magnetometer, ambient light sensor). They are designed for continuous, unobtrusive data collection, with features like comfortable materials, waterproofing, and extended battery life (up to 14-28 days). The wearables are FDA-cleared and CE MDR certified, ensuring high quality and reliability for both clinical research and routine care.
AI in Healthcare
Empatica leverages machine learning and AI to analyze biosignals collected from its wearables, enabling the development of algorithms for various health monitoring applications. This includes powerful FDA-cleared algorithms for seizure detection and alerting, as well as algorithms for stress detection with reported accuracies up to 84%. Empatica is also actively developing a seizure forecasting algorithm using real-world data from its EpiMonitor system. Their AI-powered platform aims to provide objective insights into sleep, activity, and stress levels.
Epilepsy Monitoring
Empatica's EpiMonitor system is an FDA-cleared and globally certified medical-grade solution for detecting patterns associated with generalized tonic-clonic seizures and alerting caregivers. It combines automated and manual seizure alerts with a seizure diary, alongside sleep and activity tracking. The Embrace smartband was the world's first FDA-cleared smartwatch in neurology for seizure detection. Empatica is also conducting a study to develop a seizure forecasting algorithm using real-world data from EpiMonitor users. The system is FDA-cleared for adults and children aged 6 and older.
Parkinson's Monitoring
Empatica offers an FDA-cleared Health Monitoring Platform for Parkinson's, which integrates clinically validated motor assessments from PKG Health (acquired by Empatica in 2025) with Empatica's wearable technology. This platform enables continuous tracking of motor symptoms such as bradykinesia, dyskinesia, tremor, sleep quality, and medication compliance. It provides objective, continuous monitoring to support personalized treatment decisions, improve quality of life, and reduce the burden of in-person visits. The system combines EmbraceMini, a phone app for data transfer, and PKG reports for clinicians.
Sleep Tracking
Empatica's EmbracePlus and Health Monitoring Platform offer advanced sleep tracking capabilities, including an FDA-cleared algorithm that monitors physical activity to detect sleep periods and provide sleep and wake stages for analysis. This allows for a holistic view of a patient's sleep-wake cycle and circadian rhythms. Key sleep metrics provided include Total Sleep Time, Sleep Efficiency, Sleep Onset Latency, Wake After Sleep Onset, and Sleep Fragmentation Index. The non-invasive nature of the EmbracePlus improves patient comfort and compliance, enabling continuous, longitudinal data collection in real-world settings.
Stress Monitoring
Empatica's wearables, such as the E4 and EmbracePlus, incorporate electrodermal activity (EDA) sensors, accelerometers, and heart rate sensors to measure physiological responses indicative of stress. Their technology has been used in studies to objectively measure and predict physician stress, with machine learning algorithms achieving up to 84% accuracy in detecting stress. This continuous monitoring can help identify stress periods before they are self-reported, offering opportunities for timely interventions. Empatica's research also explores how to combine EDA with other vital signs to develop novel digital biomarkers for stress.
Clinical Trials & Decentralized Clinical Trials
Empatica's Health Monitoring Platform is specifically designed for clinical trials, including decentralized clinical trials, offering a scalable, modular, and reliable solution. It provides FDA-cleared technology and dozens of accurate digital measures for high-quality data collection. The platform supports remote patient enrollment, device provisioning and shipping, continuous automated data collection, and clinical data management. It aims to reduce patient and site burden, improve patient adherence, and enable continuous, real-world data collection over extended periods. Empatica's technology has been used in over 120 industry-sponsored trials across various therapeutic areas, including neurology, endocrinology, respiratory, mental health, and cardiology.
Physician Tip

For physicians, Empatica's platform offers objective, continuous, and real-world data that can significantly enhance patient care and clinical research. The FDA-cleared digital biomarkers and wearables provide reliable insights into disease progression, treatment effectiveness, and patient response, particularly in neurology. The ability to monitor patients remotely can lead to more personalized treatment plans, earlier interventions, and reduced need for frequent in-person visits. For epilepsy, the EpiMonitor system provides crucial seizure detection and alerts, while for Parkinson's, the integrated platform offers detailed insights into motor symptoms and medication response. The comprehensive sleep and stress monitoring capabilities can also provide a more holistic view of patient health. Furthermore, access to raw data allows researchers to develop and refine their own digital biomarkers, fostering innovation in clinical practice.

The Empatica Health Monitoring Platform is designed for integration. It offers a plug-and-play SDK to integrate medical-grade data from EmbracePlus into existing healthcare provider infrastructures and Electronic Health Records (EHRs). The platform also provides access to anonymized raw data, allowing researchers to develop and refine their own digital biomarkers. All data storage and transmission comply with regulatory standards such as 21 CFR Part 11, HIPAA, and GDPR.

Products by Empatica

2 products in the directory

Care Portal
Empatica
Clinical Decision Support & Reference
Care Portal is a web-based component of the Empatica Health Monitoring Platform, designed for professionals to manage and monitor participants in various care settings and research studies. It integrates data collected from Empatica’s medical-grade wearables, such as EmbracePlus and EmbraceMini, which continuously measure physiological parameters like heart rate, electrodermal activity, motion, and skin temperature. What […]
Empatica Health Monitoring Platform
Empatica
Clinical Decision Support & Reference
Empatica Health Monitoring Platform offers a full-stack digital health solution with FDA-cleared wearables and AI-powered analytics for continuous physiological monitoring and digital biomarker development in research and clinical care.

What the Web Says

Empatica is a company that develops wearable devices for health monitoring, primarily focusing on seizure detection in individuals with epilepsy. Their products, like the EmbracePlus and EpiMonitor, have received FDA clearance for both adults and children. While some users praise the life-saving potential and accuracy of the devices, others express significant concerns regarding false alarms, undetected seizures, high subscription costs, and poor customer support. Employer reviews generally paint a positive picture of Empatica as a mission-driven company with smart and passionate employees, though some mention a lack of professional growth opportunities and mismanagement.

Overall: Mixed

Strengths

  • FDA-cleared for seizure monitoring in adults and children.
  • Potential to save lives by alerting caregivers during seizures.
  • High accuracy rate (98%) for seizure detection with minimal false alarms in newer models.
  • Employees are smart, passionate, and mission-driven.
  • Supportive and collaborative work environment.

Limitations

  • High device cost and expensive monthly subscription fees for full functionality.
  • Frequent false alarms and missed seizure detections reported by some users.
  • Poor customer support and slow response times.
  • Device disconnections and battery life issues.
  • Lack of professional growth opportunities and mismanagement cited by some employees.

Based on reviews from: apple.com, empatica.com, xtalks.com, trustpilot.com, reddit.com, comparably.com, indeed.com

Last updated: 2026-10-28

Videos

News, demos, and interviews about Empatica.

Loading videos...

Videos load interactively. If none appear, search YouTube for Empatica →

View all on YouTube

Press & Coverage

Empatica
Empatica Receives FDA Clearance for Parkinson's Monitoring
Empatica's Health Monitoring Platform for Parkinson's received 510(k) clearance from the U.S. FDA, building on their 2025 acquisition of PKG Health. This platform integrates clinically validated Parkinson's measures with Empatica's wearables for continuous symptom monitoring and personalized care.
2026-08
PR Newswire
Empatica launches WellPD, an FDA-cleared Parkinson's monitoring device for home use
Empatica announced the launch of WellPD, an FDA-cleared and CE-marked wearable device and companion app designed for individuals with Parkinson's to monitor their symptoms at home. The device tracks motor symptoms like tremor, dyskinesia, bradykinesia, as well as sleep and activity.
2026-10
Empatica
FDA Clears Empatica's EmbraceMini for Sleep Monitoring
Empatica's EmbraceMini has received 510(k) clearance from the U.S. FDA for sleep monitoring and actigraphy-based assessment of sleep patterns and circadian rhythms. This clearance establishes EmbraceMini as a medical-grade wearable for remote health monitoring in clinical trials and care.
2026-01
Empatica
Empatica receives landmark FDA PCCP authorization for pulse oximetry
Empatica achieved a landmark regulatory milestone with the U.S. FDA authorizing its pulse oximetry (SpO2) algorithm with a Predetermined Change Control Plan (PCCP). This is the first PCCP authorization for a pulse oximetry device, allowing Empatica to update its SpO2 algorithm without new 510(k) submissions.
2025-06
Empatica
Empatica Acquires PKG Health to Transform Parkinson's Disease Monitoring
Empatica announced the acquisition of PKG Health, a company specializing in movement disorder algorithms and digital endpoints for Parkinson's disease. This acquisition enhances Empatica's health monitoring platform with validated algorithms for movement disorder monitoring.
2025-10
Empatica
Empatica Secures CE MDR Certification for Parkinson's Monitoring Using PKG Measures
Empatica received CE Certification under the EU Medical Device Regulation for Parkinson's monitoring via its Health Monitoring Platform, marking the launch of its Parkinson's monitoring services for healthcare providers in Europe. This follows the acquisition of PKG Health in October 2025.
2026-01
Empatica
Empatica's Platform Receives New FDA Clearance for Cardiac Digital Biomarkers
Empatica announced FDA 510(k) clearance for two new digital biomarkers, pulse and respiratory rate, for its Health Monitoring Platform. This brings the total to six FDA-cleared digital biomarkers for use in clinical trials.
2023-11
Empatica
Empatica Selected as a Technology Partner for Government Funded Decentralized Research Program
Empatica is partnering with Allucent for PROJECT REMOTE, a decentralized COVID-19 vaccine trial funded by the U.S. Department of Health and Human Services. Empatica's EmbracePlus wearable and Health Monitoring Platform will collect continuous physiological data from 4,000 participants.
2024-10

Frequently Asked Questions

Empatica offers the Empatica Health Monitoring Platform, which includes medical-grade wearables like EmbracePlus and EmbraceMini. These devices monitor various physiological signals such as heart rate, electrodermal activity, skin temperature, and movement. The platform is used for remote patient monitoring and clinical trials across multiple therapeutic areas, including epilepsy, Parkinson's disease, sleep disorders, stress, and other neurological and health conditions.
Empatica's platform is designed to meet regulatory standards for clinical trials, with EmbracePlus and EmbraceMini being FDA-cleared medical devices and CE MDR certified. All data is stored and transmitted in compliance with regulations like 21 CFR Part 11, HIPAA, and GDPR. The platform also generates audit trails and supports IRB/ethics committee submissions.
Empatica is a pioneer in digital biomarker development, leveraging AI to provide continuous, unobtrusive remote health monitoring. Their platform offers over 300 digital measures, including FDA-cleared biomarkers for pulse rate, respiratory rate, SpO2, skin temperature, EDA, and sleep detection. These biomarkers provide objective and continuous measurements of physiological and behavioral parameters, aiding in understanding disease progression and treatment effectiveness.
Empatica's end-to-end platform supports decentralized clinical trials by covering remote patient enrollment, device provisioning, continuous automated data collection, and clinical data management. This approach aims to reduce patient and site burden, increase accessibility, and scale studies across geographical locations while providing robust, continuous physiological data.
Empatica has established partnerships to expand its digital biomarker offerings and enhance its platform. Notable collaborations include partnerships with McRoberts, PKG Health for Parkinson's monitoring, and Mobilise-D for integrating digital mobility outcomes. Empatica also partners with CROs like Allucent for government-funded decentralized research programs.
For epilepsy, Empatica offers monitoring solutions that leverage its wearable technology to provide data-driven insights for management. For Parkinson's disease, Empatica's platform, enhanced by its acquisition of PKG Health, combines validated motor assessments with FDA-cleared wearable technology to continuously track motor symptoms, treatment response, and provide objective data for personalized care.
Empatica's devices, including EmbracePlus and EmbraceMini, are used for sleep tracking, providing high-quality sleep and circadian rhythm assessments. The EmbraceMini, for example, is FDA-cleared for sleep monitoring and actigraphy-based assessment. While not explicitly detailed for stress monitoring in the provided search results, the platform's ability to measure physiological signals like electrodermal activity (EDA) and heart rate variability (HRV) suggests potential applications in stress assessment.

Investors

Who's funded Empatica.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.